Yi Hou

6.0k total citations
154 papers, 5.0k citations indexed

About

Yi Hou is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Yi Hou has authored 154 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Biomedical Engineering, 50 papers in Molecular Biology and 48 papers in Materials Chemistry. Recurrent topics in Yi Hou's work include Nanoplatforms for cancer theranostics (41 papers), Nanoparticle-Based Drug Delivery (34 papers) and Advanced biosensing and bioanalysis techniques (13 papers). Yi Hou is often cited by papers focused on Nanoplatforms for cancer theranostics (41 papers), Nanoparticle-Based Drug Delivery (34 papers) and Advanced biosensing and bioanalysis techniques (13 papers). Yi Hou collaborates with scholars based in China, United States and Canada. Yi Hou's co-authors include Mingyuan Gao, Chunyan Liu, Jianfeng Zeng, Peisen Zhang, Lihong Jing, Wensheng Yang, Zhenyu Gao, Ruirui Qiao, Tiancong Ma and Hao Lei and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Yi Hou

150 papers receiving 5.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Hou China 35 2.4k 2.1k 1.4k 1.2k 367 154 5.0k
Oliver T. Bruns† Germany 31 2.7k 1.1× 2.5k 1.2× 1.1k 0.8× 1.2k 0.9× 396 1.1× 56 6.3k
Weisheng Guo China 41 3.4k 1.4× 2.4k 1.2× 1.7k 1.2× 1.4k 1.1× 601 1.6× 107 5.9k
Adam J. Shuhendler Canada 29 3.3k 1.4× 2.1k 1.0× 1.6k 1.1× 1.0k 0.8× 670 1.8× 82 5.5k
Yuri Volkov Ireland 40 1.8k 0.7× 2.0k 1.0× 1.3k 0.9× 1.1k 0.9× 392 1.1× 110 5.1k
Bingbo Zhang China 45 2.4k 1.0× 2.6k 1.3× 1.3k 0.9× 1.0k 0.8× 377 1.0× 150 4.9k
Xinglu Huang China 41 3.0k 1.3× 2.8k 1.4× 2.2k 1.6× 2.2k 1.8× 459 1.3× 84 6.5k
Rong Zhang China 42 2.3k 1.0× 2.0k 1.0× 1.4k 1.0× 1.0k 0.9× 336 0.9× 196 6.0k
Leu‐Wei Lo Taiwan 36 2.0k 0.8× 1.7k 0.8× 1.2k 0.9× 1.5k 1.2× 526 1.4× 85 4.5k
Miriam Colombo Italy 36 1.8k 0.7× 1.2k 0.6× 1.5k 1.1× 1.8k 1.5× 245 0.7× 118 4.6k
Chuang LIU China 42 2.6k 1.1× 2.1k 1.0× 1.5k 1.1× 831 0.7× 294 0.8× 127 5.3k

Countries citing papers authored by Yi Hou

Since Specialization
Citations

This map shows the geographic impact of Yi Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Hou more than expected).

Fields of papers citing papers by Yi Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Hou. The network helps show where Yi Hou may publish in the future.

Co-authorship network of co-authors of Yi Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Hou. A scholar is included among the top collaborators of Yi Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Hou. Yi Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Min, Wenjian, Yi Hou, Dawei Wang, et al.. (2025). Discovery of Novel Small-Molecule Inhibitors Disrupting the MTDH-SND1 Protein–Protein Interaction. Journal of Medicinal Chemistry. 68(2). 1844–1862. 6 indexed citations
2.
Hou, Yi, Qin Han, Xiao Zheng, et al.. (2025). Structure-Guided Design of a Highly Selective PI3Kα Inhibitor Overcoming Metabolic Dysregulation with Potent Anti-breast Cancer Efficacy. Journal of Medicinal Chemistry. 68(22). 24404–24423.
3.
Li, Jiaxing, Yiwen Zhang, Wenjian Min, et al.. (2024). ADAR1 is required for acute myeloid leukemia cell survival by modulating post-transcriptional Wnt signaling through impairing miRNA biogenesis. Leukemia. 39(3). 599–613. 5 indexed citations
4.
Min, Wenjian, Dawei Wang, Chunling Chen, et al.. (2024). Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment. Journal of Medicinal Chemistry. 67(14). 12314–12330. 6 indexed citations
5.
Li, Yifan, Nan Wang, Lu Dong, et al.. (2024). Prodrug-inspired adenosine triphosphate–activatable celastrol-Fe(III) chelate for cancer therapy. Science Advances. 10(28). eadn0960–eadn0960. 13 indexed citations
6.
Chen, Shujiao, Bifei Li, Yi Hou, et al.. (2024). Probing the structural evolution on the surface of cardiolipin vesicles with an amphiphilic second harmonic generation and fluorescence probe. The Journal of Chemical Physics. 161(1). 3 indexed citations
7.
Tan, Jianguo, et al.. (2023). Simultaneous control of combustion instabilities and NOx emissions in a lean premixed flame using linear genetic programming. Combustion and Flame. 251. 112716–112716. 11 indexed citations
8.
Hou, Yi, et al.. (2023). Measuring the activation energy of the structural evolution in vesicle formation with combined spectroscopic methods and revealing the different ionic effects from Na+ and Ca2+. Colloids and Surfaces A Physicochemical and Engineering Aspects. 662. 130940–130940. 3 indexed citations
9.
10.
Zhang, Peisen, Yingying Cui, Jian Wang, et al.. (2023). Dual-stimuli responsive smart nanoprobe for precise diagnosis and synergistic multi-modalities therapy of superficial squamous cell carcinoma. Journal of Nanobiotechnology. 21(1). 4–4. 24 indexed citations
11.
Zhang, Peisen, Ni Zhang, Lichong Zhu, et al.. (2023). Visualizing the spatial distribution of inflammation in the depressed brain with a targeted MRI nanoprobe in vivo. NPG Asia Materials. 15(1). 4 indexed citations
12.
Huang, Jinfa, et al.. (2022). Macrophage polarisation in caesarean scar diverticulum. Journal of Clinical Pathology. 76(6). 379–383. 2 indexed citations
13.
Hou, Yi, Fang Zhang, Wenjian Min, et al.. (2022). Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors with High Selectivity, Excellent Bioavailability, and Long-Acting Efficacy for Gastric Cancer. Journal of Medicinal Chemistry. 65(14). 9873–9892. 12 indexed citations
14.
Peng, Y. Y., Bifei Li, Peng Li, et al.. (2022). Modification of the Second Harmonic Generation and Fluorescence Efficiency of D289 Dye Based on a Donor–Acceptor Structure. The Journal of Physical Chemistry C. 126(4). 2234–2242. 12 indexed citations
15.
Sun, Chengliang, Yao Cheng, Xiaojia Liu, et al.. (2022). Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents. Acta Pharmaceutica Sinica B. 12(12). 4446–4457. 25 indexed citations
16.
17.
18.
Yuan, Kai, Wenbin Kuang, Wenjian Min, et al.. (2021). Discovery of novel and orally bioavailable CDK 4/6 inhibitors with high kinome selectivity, low toxicity and long-acting stability for the treatment of multiple myeloma. European Journal of Medicinal Chemistry. 228. 114024–114024. 10 indexed citations
19.
Hou, Yi, Chao Pi, Yuanyuan Wang, et al.. (2020). Antitumor Activity In Vivo and Vitro of New Chiral Derivatives of Baicalin and Induced Apoptosis via the PI3K/Akt Signaling Pathway. Molecular Therapy — Oncolytics. 19. 67–78. 26 indexed citations
20.
Li, Jianhui, Shunli Chen, Yi Hou, et al.. (2019). Drastically modulating the structure, fluorescence, and functionality of doxorubicin in lipid membrane by interfacial density control. The Journal of Chemical Physics. 151(22). 224706–224706. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Oliver T. Bruns† Breakdown of academic impact, for papers by Weisheng Guo Breakdown of academic impact, for papers by Adam J. Shuhendler Breakdown of academic impact, for papers by Yuri Volkov Breakdown of academic impact, for papers by Bingbo Zhang Breakdown of academic impact, for papers by Xinglu Huang Breakdown of academic impact, for papers by Rong Zhang Breakdown of academic impact, for papers by Leu‐Wei Lo Breakdown of academic impact, for papers by Miriam Colombo Breakdown of academic impact, for papers by Chuang LIU
Rankless by CCL
2026